|
|
Home → Volume 1/ Issue 5 → Newer Treatments → Anti-CD20 Monoclonal Antibody (Rituximab)
162. RITUXIMAB THERAPY FOR MULTISYSTEM AUTOIMMUNE DISEASES IN
PEDIATRIC PATIENTS
BA Binstadt, HJ Weinstein, J Jackson, RC Fuhlbrigge, RP Sundel
115.
SUCCESSFUL TREATMENT OF ANTIPHOSPHOLIPID ANTIBODY
ASSOCIATED IDIOPATHIC
THROMBOCYTOPENIC PURPURA WITH RITUXIMAB
DA Wright,
M Henrickson
101.
ANTI-CD20 TREATMENT FOR REFRACTORY THROMBOCYTOPENIA
IN JUVENILE SLE
R Ten Cate, FJ Smiers, RG Bredius, AC Lankester, M van Veenendaal,
LW van Suijlekom-Smit, RM.
Egeler
102.
USE OF RITUXIMAB IN PEDIATRIC PATIENTS WITH AUTOANTIBODY-
MEDIATED BLEEDING DISORDERS ASSOCIATED WITH LUPUS
-LIKE OVERLAP SYNDROMES
PR Blier, D Rothman, PG. Sprinz
